BioLineRx and University of Illinois Enter Licensing Agreement to Develop Apoptosis Agent to Treat Cancer.
Permanent Link:
http://vlex.com/vid/biolinerx-illinois-apoptosis-treat-55968139
Id. vLex: VLEX-55968139
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Business
Business, general
Cancer
Licensing agreements
Pharmaceutical industry
Universities and colleges
Cancer treatment
Company licensing agreement
Cancer research
Apoptosis
BioLineRx and University of Illinois Enter Licensing Agreement to Develop Apoptosis Agent to Treat Cancer.
Novel Molecule BL-4030 Shown to Reduce Tumor Growth in In-Vivo Studies
JERUSALEM & URBANA, Ill. -- BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, and the University of Illinois at Urbana-Champaign announced today that they ha...Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
